HKU Scholars Hub: Browsing DSpace

Browsing by Author Ip, TP

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 6 to 25 of 28 < previous next >

Title	Author(s)	Issue Date
Changing prevalence of retinopathy in newly diagnosed non-insulin dependent diabetes mellitus patients in Hong Kong Journal:Diabetes Research and Clinical Practice	Wang, WQ Ip, TP Lam, KSL	1998
The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: A randomized placebo-controlled study Journal:Bone	Leung, JYY Ho, AYY Ip, TP Lee, G Kung, AWC	2005
Final declaration of the Asian metaforum on the role of vitamin D and the management of osteoporosis Journal:Public Health Nutrition	Chan, SP Chen, JF Chu, LW Van, DP Hosking, D Ip, TP Koh, L Kung, A Lai, NS Lau, E Lee, JK Leewattana, R Min, YK Nghia, ND Boonsong, O Park, HM Ringe, J Setyohadi, B Shin, CS Soontrapa, S Taechakraichana, N Tanjung, F Tobing, D Tsai, KS Woo, J Yang, RS	2009
Giant growth-hormone secreting pituitary tumour with extracranial extension Journal:Australasian Radiology	Ip, TP Chan, FL Kung, AWC Lam, KSL	1996
High prevalence of retinopathy in newly diagnosed NIDDM patients in Hong Kong Proceeding/Conference:IDF-WPR Congress	Wang, WQ Ip, TP Lam, KSL	1996
Hip fractures are preventable: a proposal for osteoporosis screening and fall prevention in older people Journal:Hong Kong Medical Journal	Kwok, TCY Law, SW Leung, EMF Choy, DTK Lam, PMS Leung, JCS Wong, SH Ip, TP Cheung, CL	2020
Management of osteoporosis in patients hospitalized for hip fractures Journal:Osteoporosis International	Ip, TP Leung, J Kung, AWC	2010
A multi-centered, randomized, double-blind placebo controlled study of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women Proceeding/Conference:Osteoporosis International	Kung, AWC Ip, TP Leung, J Lee, G Ho, AYY	2004
A multi-centred, randomized, double-blind placebo controlled study of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women Proceeding/Conference:Asian Regional IOF Conference on Osteoporosis	Kung, AWC Ip, TP Leung, J Lee, G	2004
OSA and atherosclerosis: Bedside and bench Proceeding/Conference:Asian Sleep Research Society (ASRS) Congress	Ip, TP	2012
The Osteoporosis Society of Hong Kong (OSHK): 2013 OSHK Guideline for Clinical Management of Postmenopausal Osteoporosis in Hong Kong Journal:Hong Kong Medical Journal	Ip, TP Cheung, SKW Cheung, TC Choi, PTF Chow, SLE Ho, HYA Kan, SYA Kung, WCA Lee, KK Leung, KLF Leung, YYJ Lo, STS Sy, CT Wong, YW	2013
Phaeochromocytoma associated with myasthenia gravis precipitated by propranolol treatment [1] Journal:Australian and New Zealand Journal of Medicine	Choi, KL Wat, MS Ip, TP Kung, AWC Lam, KSL	1995
Phaeochromocytoma with adult respiratory distress syndrome mimicking septicaemic shock Journal:Medical Journal of Australia	Mok, CC Ip, TP So, CC	1997
Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus Journal:British Journal of Clinical Pharmacology	Lam, KSL Wat, MS Choi, KL Ip, TP Pang, RWC Kumana, CR	1996
Pharmacokinetics, pharmacodynamics, long-term efficiency and safety of oral 1-deamino-8-anginine vasopressin in adult patients with central diabetes insipidus Proceeding/Conference:International Congress of Endocrinology, ICE 1996	Lam, KSL Wat, MS Choi, KL Ip, TP Kung, AWC Kumana, CR	1996
Risks of incident major osteoporotic fractures following SARS-CoV-2 infection. The Endocrine Society’s 105th Annual Meeting, Chicago, June 2023. Proceeding/Conference:The Endocrine Society’s 105th Annual Meeting (15/06/2023-18/06/2023, Chicago)	Lui, DT Xiong, X Cheung, CL Lai, FT Li, X Wan, EY Chui, CS Chan, EW Cheng, FW Chung, MS Au, IC Lee, CH Ip, TP Woo, YC Tan, KC Wong, CK Wong, IC	15-Jun-2023
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy – Interim analysis of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial Proceeding/Conference:International Congress of Chinese nephrologists	Chan, KW Kwong, ASK Lui, SL Ip, TP Chan, GCW Cowling, BJ Yiu, WH Wong, WLD LI, B LI, Y Feng, Y Tan, KCB Chan, YY Leung, JCK Lai, KN Tang, SCW	2017
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy – Preliminary results of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial Proceeding/Conference:Journal of the American Society of Nephrology	Chan, KW Kwong, ASK Lui, SL Ip, TP Chan, GCW Cowling, BJ Yiu, WH Wong, WLD Li, B Li, Y Feng, Y Tan, KCB Chan, YY Leung, JCK Lai, KN Tang, SCW	2017
Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial Journal:BMJ Open	Chan, KW Ip, TP Kwong, ASK Lui, SL Chan, GCW Cowling, BJ Yiu, WH Wong, DWL Liu, Y Feng, Y Tan, KCB Chan, LYY Leung, JCK Lai, KN Tang, SCW	2016
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy: Interim analysis of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial Proceeding/Conference:Hong Kong Medical Journal	Chan, KW Kwong, ASK Lui, SL Ip, TP Chan, GCW Cowling, BJ Yiu, WH Wong, WLD Li, B Li, Y Feng, Y Tan, KCB Chan, YY Leung, JCK Lai, KN Tang, SCW	2018

Showing results 6 to 25 of 28 < previous next >